MSF Demands Equitable Access to Bundibugyo Ebola Treatments
Doctors Without Borders (MSF) has called for equitable, non-discriminatory access to three candidate treatments—MBP134, remdesivir, and obeldesivir—currently being tested in clinical trials for Ebola caused by the Bundibugyo virus in ... Read More